NASDAQ:LFWD Lifeward Q2 2026 Earnings Report $7.82 +0.25 (+3.24%) As of 10:40 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Lifeward EPS ResultsActual EPSN/AConsensus EPS -$1.39Beat/MissN/AOne Year Ago EPSN/ALifeward Revenue ResultsActual RevenueN/AExpected Revenue$6.53 millionBeat/MissN/AYoY Revenue GrowthN/ALifeward Announcement DetailsQuarterQ2 2026Date8/14/2026TimeBefore Market OpensConference Call DateFriday, August 14, 2026Conference Call Time9:30AM ETConference Call ResourcesEarnings HistoryCompany Profile Lifeward Earnings HeadlinesLifeward Out With Q2 NumbersAugust 8, 2026 | baystreet.caLifeward to Report Second Quarter 2026 Financial Results on August 14, 2026August 7, 2026 | markets.businessinsider.comTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.August 12 at 1:00 AM | Altimetry (Ad)Lifeward (LFWD) Projected to Announce Earnings on ThursdayAugust 6, 2026 | americanbankingnews.comLifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient AccessAugust 5, 2026 | quiverquant.comQLifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal ExoskeletonAugust 5, 2026 | globenewswire.comSee More Lifeward Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lifeward? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifeward and other key companies, straight to your email. Email Address About LifewardReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.View Lifeward ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Fastly’s Q2 Rally Shows Investors Are Buying the Edge AI TurnaroundA Westinghouse IPO Could Reset the Nuclear Stock ConversationRocket Lab’s Record Quarter Still Left Investors Waiting on NeutronAtlassian Just Pulled Off the Software Comeback Wall Street WantedAST SpaceMobile Earnings Just Reminded Investors How Risky Space Can BeParamount’s 30-Film Promise Puts AMC Back in the Box Office ConversationMeta’s Muse Glimmer Release Reframes Its AI Spending Bet Upcoming Earnings Brookfield (8/13/2026)NU (8/13/2026)Applied Materials (8/13/2026)BHP Group (8/17/2026)Palo Alto Networks (8/17/2026)Home Depot (8/18/2026)Medtronic (8/18/2026)Keysight Technologies (8/18/2026)Lowe's Companies (8/19/2026)TJX Companies (8/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
